Strs Ohio Puma Biotechnology, Inc. Transaction History

Strs Ohio

$25.5 Billion
Q3 2024

A detailed history of Strs Ohio transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Strs Ohio holds 201,400 shares of PBYI stock, worth $646,494. This represents 0.0% of its overall portfolio holdings.

Number of Shares

201,400

Previous 159,300 26.43%

Holding current value

$646,494

Previous $519,000 1.16%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$2.25 - $4.03 $94,725 - $169,663	42,100 Added 26.43%	201,400 $513,000
Q2 2024 Aug 05, 2024	BUY	$2.92 - $5.83 $465,156 - $928,719	159,300 New	159,300 $519,000
Q2 2022 Jul 25, 2022	SELL	$1.64 - $3.3 $388,680 - $782,100	-237,000 Closed	0 $0
Q4 2021 Jan 24, 2022	BUY	$2.85 - $6.58 $371,640 - $858,032	130,400 Added 122.33%	237,000 $720,000
Q3 2021 Oct 22, 2021	BUY	$6.63 - $9.39 $186,303 - $263,859	28,100 Added 35.8%	106,600 $747,000
Q2 2021 Jul 26, 2021	BUY	$8.98 - $11.6 $138,292 - $178,640	15,400 Added 24.41%	78,500 $720,000
Q4 2020 Jan 25, 2021	BUY	$7.78 - $12.13 $262,186 - $408,781	33,700 Added 114.63%	63,100 $647,000
Q2 2020 Jul 23, 2020	BUY	$7.01 - $13.24 $40,658 - $76,792	5,800 Added 24.58%	29,400 $306,000
Q4 2019 Jan 24, 2020	BUY	$6.5 - $10.73 $26,650 - $43,993	4,100 Added 21.03%	23,600 $206,000
Q3 2019 Oct 21, 2019	BUY	$8.75 - $12.85 $170,625 - $250,575	19,500 New	19,500 $209,000
Q2 2018 Aug 06, 2018	SELL	$48.3 - $68.25 $806,610 - $1.14 Million	-16,700 Closed	0 $0
Q1 2018 Apr 20, 2018	BUY	$59.7 - $99.25 $149,250 - $248,125	2,500 Added 17.61%	16,700 $1.14 Million
Q4 2017 Jan 23, 2018	BUY	$93.85 - $132.45 $1.08 Million - $1.52 Million	11,500 Added 425.93%	14,200 $1.4 Million
Q3 2017 Oct 23, 2017	BUY	$72.0 - $119.75 $194,400 - $323,325	2,700	2,700 $323,000

Others Institutions Holding PBYI

# of Institutions

101

Shares Held

29M

Call Options Held

50.6K

Put Options Held

16.3K

View Full List

About PUMA BIOTECHNOLOGY, INC.

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $146M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

More about PBYI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account